scorecard

You Searched For "bharat biotech covid 19 vacine" and got 19 results


Sort By:


Business Insider Latest Story Image
2 mins read

India continues to mull over SII and Bharat Biotech's COVID-19 vaccine candidates

The Subject Expert Committee met on Wednesday to consider the Emergency Use Authorisation (EUA) …

Business Insider Latest Story Image
1 min read

Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN

Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged…

PTI   


Business Insider Latest Story Image
2 mins read

Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses

stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…

PTI   


Business Insider Latest Story Image
1 min read

Germany to recognise Bharat Biotech’s 'Covaxin' from June 1

In a tweet, Lindner said, Very happy that GER government just decided to recognize WHO-listed Covax…

Business Insider Latest Story Image
1 min read

DCGI gives nod to Bharat Biotech's Covaxin for 6-12 age group in India

The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event w…

Business Insider Latest Story Image
2 mins read

Expert committee recommends Bharat Biotech’s Covaxin for kids aged between 2-18 years

According to media reports, the Hyderabad-based Bharat Biotech had successfully completed its Ph…

Business Insider Latest Story Image
2 mins read

Ideal time for COVID-19 booster shot is six months after the second dose, says Bharat Biotech MD

"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…

PTI   


Business Insider Latest Story Image
3 mins read

India's Covaxin 77.8% effective for COVID-19, says Lancet Report

A"The efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic…

Business Insider Latest Story Image
4 mins read

Supreme Court wants the Indian government to explain vaccine pricing — and clarify how many doses it will need as coverage expands from May 1

The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…

Business Insider Latest Story Image
2 mins read

WHO approves Bharat Biotech’s Covaxin for emergency use after a long wait

The WHO, in a tweet, said: "WHO has granted emergency use listing (EUL) to Covaxin, developed by…

Business Insider Latest Story Image
3 mins read

Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports

Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…

Business Insider Latest Story Image
3 mins read

Covaxin supply to government at ₹150 per dose is not sustainable, says Bharat Biotech

The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …

Business Insider Latest Story Image
3 mins read

Covaxin shows 50% effectiveness against symptomatic COVID-19 in real-world assessment, says Lancet study

The results of an interim study recently published in The Lancet showed that two doses of Covaxi…

PTI   


Business Insider Latest Story Image
4 mins read

OPINION: No matter what Bharat Biotech says, Covaxin is just not ready for approvals

Benefits like how effective the vaccine is in preventing disease, and risks such as high morta…

Business Insider Latest Story Image
2 mins read

Bharat Biotech's COVID-19 vaccine COVAXIN is well tolerated with no serious adverse events as per phase 1 trial results

A preprint is a version of a scientific manuscript posted on a public server prior to formal pe…

PTI   


Business Insider Latest Story Image
4 mins read

Bharat Biotech sees rivals’ conspiracy in all the criticism for the approval for Covaxin

Bharat Biotech chairman and managing director, Krishna Ella, believes that the gossip-mongering …

Business Insider Latest Story Image
1 min read

After Serum Institute of India, Bharat Biotech says it will reduce the cost of COVAXIN for state governments

Bharat Biotech, the company behind the COVID-19 vaccine COVAXIN, has slashed the price of its vacci…

Business Insider Latest Story Image
2 mins read

Covaxin shows 77.8% effectiveness against symptomatic COVID-19 cases in phase-3 trials

The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptoma…

PTI   


Business Insider Latest Story Image
1 min read

CAT admit card 2020 to be released today. Here’s how to download

The Indian Institute of Management (IIM), Indore is likely to release the admit card for Common Adm…